NO942660D0 - Fremgangsmåte til bestemmelse av cytolytiske T-celle-forstadier - Google Patents

Fremgangsmåte til bestemmelse av cytolytiske T-celle-forstadier

Info

Publication number
NO942660D0
NO942660D0 NO942660A NO942660A NO942660D0 NO 942660 D0 NO942660 D0 NO 942660D0 NO 942660 A NO942660 A NO 942660A NO 942660 A NO942660 A NO 942660A NO 942660 D0 NO942660 D0 NO 942660D0
Authority
NO
Norway
Prior art keywords
cell precursors
determining cytolytic
cytolytic
determining
precursors
Prior art date
Application number
NO942660A
Other languages
English (en)
Other versions
NO942660L (no
Inventor
Pierre G Coulie
Thierry Boon
Original Assignee
Ludwig Inst Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Inst Cancer Res filed Critical Ludwig Inst Cancer Res
Publication of NO942660D0 publication Critical patent/NO942660D0/no
Publication of NO942660L publication Critical patent/NO942660L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO942660A 1992-01-21 1994-07-15 Fremgangsmåte til bestemmelse av cytolytiske T-celle-forstadier NO942660L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82393392A 1992-01-21 1992-01-21
PCT/US1993/000083 WO1993014189A1 (en) 1992-01-21 1993-01-07 Method for determining cytolytic t cell precursors

Publications (2)

Publication Number Publication Date
NO942660D0 true NO942660D0 (no) 1994-07-15
NO942660L NO942660L (no) 1994-09-16

Family

ID=25240169

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942660A NO942660L (no) 1992-01-21 1994-07-15 Fremgangsmåte til bestemmelse av cytolytiske T-celle-forstadier

Country Status (8)

Country Link
EP (1) EP0624189A4 (no)
JP (1) JPH07503134A (no)
KR (1) KR950700402A (no)
AU (1) AU3435293A (no)
CA (1) CA2128424A1 (no)
FI (1) FI943422A0 (no)
NO (1) NO942660L (no)
WO (1) WO1993014189A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU664560B2 (en) * 1991-05-23 1995-11-23 Ludwig Institute For Cancer Research Tumor rejection antigen precursors, tumor rejection antigens and uses thereof
US6280962B1 (en) 1991-11-25 2001-08-28 Yoreh Biotechnologies Ltd. Whole blood/mitogen assay for the early detection of a subject with cancer and kit
US6322989B1 (en) 1991-11-25 2001-11-27 Yoreh Biotechnologies, Ltd. Whole blood/mitogen assay for the early detection of a subject with ovarian or breast cancer and kit
US6352826B1 (en) 1991-11-25 2002-03-05 Yoreh Biotechnologies, Ltd. Method and kit for the detection of retroviral specific antibodies in seronegative individuals
US5874560A (en) 1994-04-22 1999-02-23 The United States Of America As Represented By The Department Of Health And Human Services Melanoma antigens and their use in diagnostic and therapeutic methods
WO1995029193A2 (en) 1994-04-22 1995-11-02 The Government Of The United States Of America Represented By The Secretary, Department Of Health And Human Services Melanoma antigens
US5843648A (en) * 1995-01-10 1998-12-01 The United States Of America As Represented By The Secretary, Department Of Health And Human Services P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
US6951917B1 (en) 1995-09-26 2005-10-04 The United States Of America As Represented By The Department Of Health And Human Services MHC-class II restricted melanoma antigens and their use in therapeutic methods
US7501501B2 (en) 1995-09-26 2009-03-10 The United States Of America As Represented By The Secretary Department Of Health And Human Services MHC-Class II restricted melanoma antigens and their use in therapeutic methods
ATE244300T1 (de) * 1996-01-17 2003-07-15 Imp College Innovations Ltd Immunotherapie mit verwendung von zytotoxischen t lymphozyten (ctl)
US20040156861A1 (en) 1996-07-11 2004-08-12 Figdor Carl Gustav Melanoma associated peptide analogues and vaccines against melanoma
CA2272924A1 (en) * 1996-11-22 1998-05-28 Shiloov Medical Technologies Ltd. A whole blood/mitogen assay for the early detection of a subject with cancer and kit

Also Published As

Publication number Publication date
JPH07503134A (ja) 1995-04-06
AU3435293A (en) 1993-08-03
WO1993014189A1 (en) 1993-07-22
EP0624189A1 (en) 1994-11-17
EP0624189A4 (en) 1995-05-17
CA2128424A1 (en) 1993-07-22
FI943422A (fi) 1994-07-19
NO942660L (no) 1994-09-16
KR950700402A (ko) 1995-01-16
FI943422A0 (fi) 1994-07-19

Similar Documents

Publication Publication Date Title
FI931736A0 (fi) Biodegraderbart tgf-b-leveranssystem foer benregeneration
AU2969284A (en) Prestressed component retaining wall system
NO942660D0 (no) Fremgangsmåte til bestemmelse av cytolytiske T-celle-forstadier
FI933800A0 (fi) Klammer foer sammanbindande av kantprofiler foer skaolningsplattor
EP0471532A3 (en) Method for determining the size of a memory
FI931121A0 (fi) Bockningspress foer framstaellning av boejda glasrutor
ITUD920118A0 (it) Gruppo avvolgitore-svolgitore per bramme sottili
AU8835591A (en) Lath grating for supporting matresses
NO924013D0 (no) Lyslist for nivaaglass
DK0604060T3 (da) Fremgangsmåde til fremstilling af riboflavin
DK0509342T3 (da) Fremgangsmåde til fremstilling af kileformede strukturer
FI945946A0 (fi) Menetelmä fosforin poistamiseksi
DK0648279T3 (da) Acceptor for fucosultransferase
FI930710A (fi) Anordning foer oevervakning av vaetskenivao
DK34083A (da) Indretning til et lagersystem
DK164962C (da) Taekkenaal til straatag
FI934756A0 (fi) Anordning foer avlaegsnande av utstansade delar
GR2000634Y (en) Therablock-construction element for walls
DK149989D0 (da) Taetningssystem for skuffer
FI921441A (fi) Anordning foer framstaellning av en spaelgardin
RU1753845C (en) Method for gamma-spectroscopic survey
RU1753846C (en) Method for aerogeophysical survey
GB9026498D0 (en) Brick facing system
GB9026031D0 (en) Brick facing system
LV10130A (lv) Parklajuma biezuma noteiksanas panemiens